LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
11.20
-0.19 (-1.67%)
Dec 5, 2025, 4:00 PM EST - Market closed
LENSAR Market Cap
LENSAR has a market cap or net worth of $133.78 million as of December 5, 2025. Its market cap has increased by 58.87% in one year.
Market Cap
133.78M
Enterprise Value
119.79M
1-Year Change
58.87%
Ranking
Category
Stock Price
$11.20
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $133.78M, an increase of 71.50%. That is a compound annual growth rate of 10.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 136.05M | 31.02% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |